esophageal cancer
Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test
Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device.
Lucid Diagnostics Gets CE Mark for Esophageal Cell Collection Device
The device is a swallowable balloon capsule catheter that allows physicians to sample surface cells from the esophagus in a noninvasive office procedure.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.
Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test
The firm presented initial study results from the test, which identifies six cancers, showing overall sensitivity at 86 percent and specificity of 95 percent.
Cernostics, Deciphex to Collaborate on AI-Based Histology in Barrett's Esophagus
Cernostics offers an assay that analyzes whole-slide digital images with multiplexed fluorescence to help interpret Barrett's esophagus patient biopsies.
Aug 6, 2020
PavMed Raises $7M in Private Funding Round
Aug 13, 2019
Interpace Diagnostics Q2 Revenues Climb 14 Percent
Feb 11, 2019
Nov 13, 2018
Interpace Diagnostics Q3 Revenues Up 38 Percent
Aug 9, 2018